课题基金 / 基金详情

Partnership in Cancer Research (PCAR)

Partnership in Cancer Research (PCAR)
癌症研究合作伙伴 (PCAR)
批准号:
10676820
负责人:
THOMAS JOSEPH KELLY
金额:
$7.75万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-08-31

项目摘要

项目成果

THOMAS JOSEPH KELLY的其他基金

相似基金

相关文献

中文摘要
翻译
癌症研究伙伴关系(PCAR)旨在为一年级和二年级的医学生提供一个 在实验室,临床或社区环境中的创新实践癌症研究经验。PCAR 暑期课程将为12名学员提供为期10周的培训。研究经验将 通过基于团队的癌症分子和细胞生物学学习以及临床模拟来丰富 以及癌症筛查、治疗和缓解的经验。癌症研究的首要目标 经验是激发参与者对未来癌症临床专家职业的兴趣, 研究人员该计划将加强劳动力的培训,以满足国家的生物医学,行为, 临床研究需要。 个人癌症研究项目是学生花费大部分时间的地方。这项研究将 每周一次的癌症生物学主动学习课程。临床经验将暴露 参与者在治疗和癌症患者的持续护理的当前问题;这方面也将给予 参与者深入了解基础和社区参与的科学如何影响临床实践,以及临床如何 问题可以转化为研究问题。创业计划的特点是团队3 参与者通过每周会议独立提出可销售的癌症研究解决方案, 企业家导师其目的是: 1)为个别医学生提供癌症研究方面的杰出实践经验。 学生将与大约50名不同的教职员工进行癌症研究, 基础科学、临床研究或社区参与研究。在整个过程中, 参与者将把他们的研究经验和想法整合到在线和面对面指导的“治愈”中, 癌症创业计划”。 2)为参与者的研究提供基于团队的学习和临床接触的背景。 每周的团队学习课程将让学生学习分子和生物学的详细信息, 癌症的细胞生物学,以及社区医学的原则。临床暴露包括 癌症相关主题的动手医学模拟,与适度患者的社交媒体互动 支持小组,并访问姑息治疗诊所,每周不超过2小时。 3)通过严格的评估确定项目成果。测试前和测试后将用于 决定学生在癌症研究知识的增益。将利用调查来评价 课程内容,教师和活动。长期跟踪参与者和类似规模的医疗队列 没有参加PCAR的学生将被用来调查影响职业选择的有效性, 癌症研究。
英文摘要
Partnership in Cancer Research (PCAR) seeks to provide first and second-year medical students an innovative hands-on cancer research experience in a laboratory, clinical, or community setting. The PCAR experience will serve a class of 12 participants for 10 weeks during the summer. The research experience will be enriched by team-based learning on the molecular and cell biology of cancer alongside clinical simulations and experiences of cancer screening, treatment, and palliation. The overarching goal of the cancer research experiences is to spark the participants’ interest in future careers as cancer clinical specialists and researchers. The program will enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs. Individual cancer research projects are where the students spend most of their time. The research will be put into context with weekly active learning sessions on the biology of cancer. Clinical experiences will expose participants to current issues in the treatment and ongoing care of people with cancer; this aspect will also give participants insight into how basic and community-engaged science affect clinical practice and how clinical problems can be turned into research questions. The entrepreneurship program features teams of 3 participants independently proposing marketable cancer research solutions through weekly sessions with entrepreneur mentors. The aims are to: 1) Provide individual medical students an outstanding hands-on experience in cancer research. Students will perform research with one of about 50 different faculty members performing cancer research in basic science, clinical research, or community engaged research. Throughout the course, teams of participants will integrate their research experiences and ideas in the online and in-person mentored “Cure Cancer Entrepreneurship program” . 2) Provide context for participants’ research with team-based learning and clinical exposures. Weekly team-based learning sessions will engage students in learning detailed information on molecular and cellular biology of cancer, as well as principles of community based medicine. Clinical exposure includes hands-on medical simulations of cancer related topics, social media interaction with a moderated patient support group, and a visit to the palliative care clinic that will take up no more than 2 hours per week. 3) Determine program outcomes through rigorous evaluation. Pre and post testing will be used to determine students gain in cancer research knowledge. Surveys will be used to evaluate all aspects of the course content, faculty, and activities. Long term tracking of participants and similar sized cohort of medical students who did not participate in PCAR will be used to investigate efficacy in influencing career choice in cancer research.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/ijms22158199
发表时间: 2021-07-30
期刊: International journal of molecular sciences
影响因子: 5.6
作者: [Kiss RC, Xia F, Acklin S]
通讯作者: Acklin S
Partnership in Cancer Research (PCAR)
  • 批准号:
    10222627
  • 项目类别:
  • 资助金额:
    $15.6万
  • 财政年份:
    2020
  • 负责人:
    THOMAS JOSEPH KELLY
  • 依托单位:
Partnership in Cancer Research (PCAR)
  • 批准号:
    10470140
  • 项目类别:
  • 资助金额:
    $15.6万
  • 财政年份:
    2020
  • 负责人:
    THOMAS JOSEPH KELLY
  • 依托单位:
Partnership in Cancer Research (PCAR)
  • 批准号:
    10024400
  • 项目类别:
  • 资助金额:
    $15.6万
  • 财政年份:
    2020
  • 负责人:
    THOMAS JOSEPH KELLY
  • 依托单位:
MEMBRANE PROTEASES INVOLVED IN TRANSFORMED CELL INVASION
  • 批准号:
    3034063
  • 项目类别:
  • 资助金额:
    $2.6万
  • 财政年份:
    1991
  • 负责人:
    THOMAS JOSEPH KELLY
  • 依托单位:
海外基金